Get the latest delivered to your inbox
Privacy Policy

Now Reading

Biogen Receives Gold Class Distinction in S&P Global Sustainability Yearbook

Biogen Receives Gold Class Distinction in S&P Global Sustainability Yearbook

Published 02-18-22

Submitted by Biogen

Biogen was recently included in S&P Global's Sustainability Yearbook 2022, which assessed over 7,500 companies in the 2021 Corporate Sustainability Assessment (CSA). Only 716 companies with top scores made it into the Yearbook this year.

Earning S&P Global’s Gold Class Distinction is the culmination of significant work by our colleagues across the world – from Healthy Climate, Healthy Lives to the implementation of our DE&I strategy.

We are honored to be recognized in this year’s Sustainability Yearbook.

See the full Sustainability Yearbook 2022

Biogen Logo

Biogen

Biogen

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

More from Biogen

Join today and get the latest delivered to your inbox